BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28341816)

  • 1. Increased Expression of Toll-Like Receptors 2 and 4 in Renal Transplant Recipients that Develop Allograft Dysfunction: A Cohort Study.
    Hosseinzadeh M; Nafar M; Ahmadpoor P; Noorbakhsh F; Yekaninejad MS; Niknam MH; Amirzargar A
    Iran J Immunol; 2017 Mar; 14(1):24-34. PubMed ID: 28341816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft dysfunction; a cohort study.
    Hosseinzadeh M; Ahmadpoor P; Yekaninejad MS; Pourrezagholi F; Foroughi F; Ghorbanpour M; Barabadi M; Shahbaz SK; Solgi G; Amirzargar A
    Transpl Immunol; 2018 Jun; 48():26-31. PubMed ID: 29452169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
    Zmonarski SC; Madziarska K; Golebiowski T; Banasik M; Mazanowska O; Madziarski M; Krajewska M
    Transpl Immunol; 2019 Apr; 53():43-50. PubMed ID: 30592973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR-2, TLR-4 and MyD88 genes expression in renal transplant acute and chronic rejections.
    Sharbafi MH; Assadiasl S; Pour-Reza-Gholi F; Barzegari S; Mohammadi Torbati P; Samavat S; Nicknam MH; Amirzargar A
    Int J Immunogenet; 2019 Dec; 46(6):427-436. PubMed ID: 31286693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal expression of Toll-like receptor 2 and 4: dynamics in human allograft injury and comparison to rodents.
    Stribos EG; van Werkhoven MB; Poppelaars F; van Goor H; Olinga P; van Son WJ; Damman J; Seelen MA
    Mol Immunol; 2015 Mar; 64(1):82-9. PubMed ID: 25465639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential monitoring of TIM-3 mRNA expression in blood and urine samples of renal transplant recipients.
    Shahbaz SK; Barabadi M; Ahmadpour P; Pourrezagholi F; Nafar M; Foroughi F; Hosseinzadeh M; Ghorbanpour M; Yekaninejad MS; Amirzargar A
    Transpl Immunol; 2019 Jun; 54():9-16. PubMed ID: 30395925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation.
    Deng JF; Geng L; Qian YG; Li H; Wang Y; Xie HY; Feng XW; Zheng SS
    Transplant Proc; 2007 Dec; 39(10):3222-4. PubMed ID: 18089358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine as a modulator of the immune system of critical care patients: effect on Toll-like receptor expression. A preliminary study.
    Pérez-Bárcena J; Regueiro V; Marsé P; Raurich JM; Rodríguez A; Ibáñez J; de Lorenzo Mateos AG; Bengoechea JA
    Nutrition; 2008 Jun; 24(6):522-7. PubMed ID: 18367379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.
    Boersema M; van den Born JC; van Ark J; Harms G; Seelen MA; van Dijk MC; van Goor H; Navis GJ; Popa ER; Hillebrands JL
    Immunobiology; 2015 May; 220(5):673-83. PubMed ID: 25476849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 and renal allograft function.
    de Groot K; Kuklik K; Bröcker V; Schwarz A; Gwinner W; Kreipe H; Haller H; Fliser D; Mengel M
    Am J Nephrol; 2008; 28(4):583-8. PubMed ID: 18264007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
    Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
    Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TLR-4 and -2 in peripheral mononuclear cells in renal transplant patients with TLR-4 gene polymorphism.
    Nogueira E; Salomao R; Brunialti MK; Ozaki KS; Marques GD; Cenedeze MA; Câmara NO; Pacheco-Silva A
    Int Immunopharmacol; 2010 Dec; 10(12):1481-5. PubMed ID: 20951669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
    Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of toll-like receptors in multifactorial mechanisms of early and late renal allotransplant injury, with a focus on the TLR4 receptor and mononuclear cells.
    Zmonarski SC; Banasik M; Madziarska K; Mazanowska O; Krajewska M
    Adv Clin Exp Med; 2019 Jul; 28(7):981-987. PubMed ID: 30968609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of expression of Toll-like receptor 4 early after renal transplantation: a clinical research].
    Yu YM; Yu LX; Liu YJ; Deng WF
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2238-40. PubMed ID: 18001540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation state and function of monocyte derived dendritic cells in liver transplant recipients.
    Shariat A; Karimi MH; Mokhtariazad T; Moazzeni SM; Geramizadeh B; MalekHosseini SA; Yaghobi R
    Iran J Immunol; 2014 Sep; 11(3):153-65. PubMed ID: 25266001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 and TLR4 expression on CD14(++) and CD14(+) monocyte subtypes in adult-onset autoimmune diabetes.
    Cejkova P; Nemeckova I; Broz J; Cerna M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):76-83. PubMed ID: 25942429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation.
    Krichen H; Gorgi Y; Dhaouadi T; Mecheri Y; Sfar I; Bardi R; Bacha MM; Abderrahim E; Jendoubi-Ayed S; Ayed K; Ben Abdallah T
    Transplant Proc; 2013; 45(10):3472-7. PubMed ID: 24314935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.